Lataa...
Adaptive mechanisms of Campylobacter jejuni to erythromycin treatment
BACKGROUND: Macrolide is the drug of choice to treat human campylobacteriosis, but Campylobacter resistance to this antibiotic is rising. The mechanisms employed by Campylobacter jejuni to adapt to erythromycin treatment remain unknown and are examined in this study. The transcriptomic response of C...
Tallennettuna:
| Päätekijät: | , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3694039/ https://ncbi.nlm.nih.gov/pubmed/23767761 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2180-13-133 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|